Connection

JEFFREY STARKE to Cost-Benefit Analysis

This is a "connection" page, showing publications JEFFREY STARKE has written about Cost-Benefit Analysis.
Connection Strength

0.119
  1. Safety and completion of a 4-month course of rifampicin for latent tuberculous infection in children. Int J Tuberc Lung Dis. 2014 Sep; 18(9):1057-61.
    View in: PubMed
    Score: 0.098
  2. Cost-effectiveness of latent tuberculosis screening before steroid therapy for idiopathic nephrotic syndrome in children. Am J Kidney Dis. 2013 Jan; 61(1):22-32.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.